Waldencast plc (WALD)
Technology
- Fundamental
- 2
- Sentiment
- 3
- Technical
- 2
Do Nothing: fundamentalScore is 2 (below required floor of 3); this strategy requires fundamentalScore >= 3 before any bullish entry. Separately, avgDollarVolume20 is only 1913342.91, below the 5000000 liquidity floor, and the chart itself scores 2/5 after a high-volume post-spike fade.
Company overview
Waldencast plc is a skincare company specializing in treatments for dermatological conditions such as early aging, skin damage, and uneven pigmentation. Its products are distributed through professional channels including dermatologists and medical spas. The company's offerings include the Obagi Medical and Obagi Clinical lines, focusing on anti-aging and skin protection.
Fundamental
weakWaldencast's fundamentals are weak, with negative margins and cash flow, and high leverage risk.
WALD’s fundamentals are currently weak: FY2025 revenue was $272.1M (flat YoY) and profitability deteriorated to a -84.44% net margin, with a negative free-cash-flow yield (-9.41%). Balance-sheet risk is elevated (Altman Z-Score -0.87; interest coverage -2.46) with about $149.0M of debt versus about $31.9M of cash. SEC filings highlight liquidity/covenant and internal-control risks, but also a major potential de-leveraging catalyst: a June 2026 agreement to sell the Obagi business for up to $460M, with proceeds earmarked for debt repayment. Valuation looks low on EV/Sales (~1.06x), yet discounted-cash-flow outputs are negative, reflecting cash burn and uncertainty. FundamentalScore: 2/5.
Sentiment
fairSentiment is mixed, with positive regulatory news but uncertainty around the Obagi sale.
Near-term narrative is driven by the 2026-06-15 FDA approval for Obagi saypha ChIQ (regulator_confirmed, bullish) and the ongoing Obagi Medical divestiture to Bridgepoint (announced; closing TBD). Media sentiment is slightly more constructive in the last ~14d than the mixed 30–90d baseline (low confidence due to sparse coverage), Reddit is indeterminate due to rate limits, and the legal screen/Red-Flag Screen is clean with the SEC closing its prior accounting probe without enforcement.
Technical
weakTechnical indicators suggest a bearish trend with the stock below key moving averages.
Price has lost short-term control after the June spike, closing below EMA9, EMA21, SMA20, SMA200, and the daily VWAP while only holding above SMA50. RSI14 at 43.57 and a MACD histogram of -0.05 show fading momentum, and ADX14 at 31.07 says the current downswing has real trend strength. Williams %R at -97.92 leaves room for a reflex bounce, but the evidence supports only a weak bounce candidate, not a strong bullish chart.
You’re looking at 2026-06-26 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Technology
Not financial advice. For informational and educational purposes only.